BioCentury | Feb 2, 2021
Politics, Policy & Law
Biopharma execs push back on Rep. Porter’s push to rein in M&A
Rep. Katie Porter (D-Calif.), a rising voice in the progressive wing of the Democratic Party, has released a report that portrays biopharma mergers and acquisitions as harmful to innovation and recommends laws that would slow...